Literature DB >> 29206324

AHNS Series: Do you know your guidelines? Evidence-based management of oral cavity cancers.

Amarbir Gill1, Nilesh Vasan2, Babak Givi3, Arjun Joshi4.   

Abstract

Oral cavity squamous cell carcinoma (OCSCC) is the most common nonmelanoma head and neck cancer in the world, with an estimated 405 000 new cases expected each year. Subsites of the oral cavity include the alveolar ridge, buccal mucosa, anterior tongue, tonsillar pillar, retromolar trigone, hard palate, gingiva, and floor of the mouth. In this issue of the AHNS "Do you know your guidelines?" series, we review the evidence-based approach to the management of oral cavity carcinomas based on the framework provided by the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  evidence based; guidelines; head and neck cancer; oral cavity; review

Mesh:

Year:  2017        PMID: 29206324     DOI: 10.1002/hed.25024

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  2 in total

1.  Efficacy of different sentinel lymph node biopsy protocols in oral squamous cell carcinoma: Systematic review and meta-analysis.

Authors:  Maria Suárez Ajuria; Mercedes Gallas Torreira; Abel García García; Xabier Marichalar Mendía; Cintia M Chamorro Petronacci; Elena Padín Iruegas; Mario Pérez Sayáns
Journal:  Head Neck       Date:  2022-03-31       Impact factor: 3.821

2.  Real-World Outcomes and Prognostic Factors in Patients Receiving Nivolumab Therapy for Recurrent or Metastatic Head and Neck Carcinoma.

Authors:  Ryusuke Hori; Shogo Shinohara; Tsuyoshi Kojima; Hiroki Kagoshima; Morimasa Kitamura; Ichiro Tateya; Hisanobu Tamaki; Yohei Kumabe; Ryo Asato; Hiroyuki Harada; Yoshiharu Kitani; Takashi Tsujimura; Keigo Honda; Kazuyuki Ichimaru; Koichi Omori
Journal:  Cancers (Basel)       Date:  2019-09-06       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.